Maxon Motor has announced that it will expand its Swiss headquarters with the construction of a CHF 30 million Innovation Centre. The new facility will provide space for the research, development and production of medical drives, the company reports.
The expanded medical department will utilise double its current floor space, over a floor area of more than 2,000m2 (nearly 25,000 ft2). Here, the smallest Maxon motors will be manufactured, some with a thickness of only 4mm (0.16 in). These motors are used in applications such as insulin pumps, medication delivery systems and surgical robots.
In order to meet the stringent quality demands of the medical field, the production area will be equipped with clean rooms, including a biocompatible room. With these measures, Maxon Motor hopes to form the basis for further growth in this important field.
Maxon Motor has more than thirty sales companies and six production sites worldwide, including its own facility for Metal Injection Moulding and Ceramic Injection Moulding in Sexau, Germany. The company employs more than 1,200 staff at its Obwalden headquarters, Switzerland, where the expansion will take place.
Following the expansion, the company reports that it expects to place a stronger focus on research & development, medical technology, complete drive systems (mechatronics) and Industry 4.0. Eugen Elmiger, Maxon CEO, stated, “The new Innovation Centre is a move to strengthen our Swiss headquarters in order to become stronger internationally.”
Maxon will invest approximately CHF 30 million in the Innovation Center.